Riccio, A. M., Mauri, P., De Ferrari, L., Rossi, R., Di Silvestre, D., Benazzi, L., . . . Canonica, G. W. (2017). Galectin-3: An early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months. Clin Transl Allergy.
Citação norma ChicagoRiccio, Anna Maria, et al. "Galectin-3: An Early Predictive Biomarker of Modulation of Airway Remodeling in Patients With Severe Asthma Treated With Omalizumab for 36 months." Clin Transl Allergy 2017.
MLA引文Riccio, Anna Maria, et al. "Galectin-3: An Early Predictive Biomarker of Modulation of Airway Remodeling in Patients With Severe Asthma Treated With Omalizumab for 36 months." Clin Transl Allergy 2017.
警告:這些引文格式不一定是100%准確.